User profiles for Gwilym J Webb
Gwilym WebbUniversity of Birmingham Verified email at bham.ac.uk Cited by 4019 |
[HTML][HTML] COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID-19) has …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID-19) has …
[HTML][HTML] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
[HTML][HTML] FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting
enzyme 2 (ACE2) 1 , could represent a new chemoprophylactic approach for …
enzyme 2 (ACE2) 1 , could represent a new chemoprophylactic approach for …
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry
[1] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality
of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020…
of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020…
[HTML][HTML] Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Background Despite concerns that patients with liver transplants might be at increased risk
of adverse outcomes from COVID-19 because of coexisting comorbidities and use of …
of adverse outcomes from COVID-19 because of coexisting comorbidities and use of …
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …
virus can lead to serious systemic consequences affecting major organs including the …
OX40, OX40L and autoimmunity: a comprehensive review
GJ Webb, GM Hirschfield, PJL Lane - Clinical reviews in allergy & …, 2016 - Springer
The tumour necrosis factor receptor OX40 (CD134) is activated by its cognate ligand OX40L
(CD134L, CD252) and functions as a T cell co-stimulatory molecule. OX40-OX40L …
(CD134L, CD252) and functions as a T cell co-stimulatory molecule. OX40-OX40L …
[HTML][HTML] SARS-CoV-2 infection in patients with autoimmune hepatitis
Background & Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
coronavirus disease 2019 (COVID-19) continues to have a devastating impact across the …
coronavirus disease 2019 (COVID-19) continues to have a devastating impact across the …
Determining risk factors for mortality in liver transplant patients with COVID-19
We read with great interest the Correspondence from Bhoori and colleagues1 describing
the effect of coronavirus disease 2019 (COVID-19) on their centre’s adult liver transplant …
the effect of coronavirus disease 2019 (COVID-19) on their centre’s adult liver transplant …
No gains in long-term survival after liver transplantation over the past three decades
Objective: The aim of this study was to assess improvements in long-term survival after liver
transplant by analyzing outcomes in transplant recipients who survived beyond 1 year. …
transplant by analyzing outcomes in transplant recipients who survived beyond 1 year. …